Cat:GMP-h-ADPN
* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry
SKU GMP-h-ADPN Categories ,

Product Details

Genemedi produces core diagnostic ingredients for test of Diabetes diseases (diabetes, obesity and atherosclerosis) and related syndrome. GeneMedi offers paired diagnostics grade Adiponectin (ADPN) antibodies (monoclonal antibody, mab) and antigens for Diabetes diseases (diabetes, obesity and atherosclerosis) rapid test kit of Adiponectin (ADPN) testing in standard substance, positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT. All the antibodies and antigens for Diabetes diseases (diabetes, obesity and atherosclerosis ) test are suitable for in functional ELISA, and other immunoassays in dignostics.The antibodies can act as a capture antibody and detection antibody. The antigens can be used as positive control.Adiponectin is a protein hormone and adipokine, which is involved in regulating glucose levels as well as fatty acid breakdown. Adiponectin is the most abundant peptide secreted by adipocytes, whose reduction plays a central role in obesity-related diseases, including insulin resistance/type 2 diabetes and cardiovascular disease. In addition to adipocytes, other cell types, such as skeletal and cardiac myocytes and endothelial cells, can also produce this adipocytokine. Adiponectin effects are mediated by adiponectin receptors, which occur as two isoforms (AdipoR1 and AdipoR2). Adiponectin has direct actions in liver, skeletal muscle, and the vasculature. Adiponectin exists in the circulation as varying molecular weight forms, produced by multimerization.Direct administration of adiponectin has been shown to be beneficial in animal models of diabetes, obesity and atherosclerosis.

Product Description

Cat No. of Pruducts

GMP-h-ADPN-Ag01:Recombinant Human ADPN Protein

Product Name

Recombinant Human ADPN Protein

Target

Adiponectin

Alias of Target/Biomarker

ACDC, ACRP30, ADIPQTL1, ADPN, APM-1, APM1, GBP28, ADIPOQ

Expression platform

E.coli

Isotypes

Recombinant Antigen

Bioactivity validation

Adiponectin (ADPN) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in ADPN level test of Diabetes diseases (diabetes, obesity and atherosclerosis) and related syndrome evaluation

Tag

His

Products description

Recombinant Human ADPN Protein was expressed in E.coli -based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.

Reconized/Reactive Species

Human

Purity

Purity: ≥95% (SDS-PAGE)

Application

Standard substance, positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA),immunonephelometry and POCT.

Formulation

Supplied as a 0.2 μM filtered solution of PBS,PH7.4.

Storage

Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.
Genemeidi Omicron Variant Products
test
Previous slide
Next slide

Cat No. of Pruducts

GMP-h-ADPN-Ab01,GMP-h-ADPN-Ab02:Anti-Human ADPN mouse monoclonal antibody (mAb)

Product Name

Anti-Human ADPN mouse monoclonal antibody (mAb)

Target

Alias of Target/Biomarker

ACDC, ACRP30, ADIPQTL1, ADPN, APM-1, APM1, GBP28, ADIPOQ

Expression platform

Hybridoma

Isotypes

Mouse IgG

Bioactivity validation

Human Adiponectin (ADPN) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Adiponectin (ADPN) antibodies in ADPN level test of Diabetes diseases (diabetes, obesity and atherosclerosis) and related syndrome evaluation.

Tag

mFc

Products description

Anti-Human ADPN mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by hybridoma technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other Adiponectin (ADPN) antibodies.

Reconized/Reactive Species

Human

Purity

Purity: ≥95% (SDS-PAGE)

Application

ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT

Formulation

Supplied as a 0.2 μM filtered solution of PBS,PH7.4.

Storage

Store at? -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Diagnostic antibodies and antigens for cancer detection - TG, CA-125, SCC Ag, PIVKA-Ⅱ, ProGRP, Calcitonin, NSE, CA-724, HE4, CA15-3, FER, CYFRA21-1, HER2, HSP90α, S100B, CEA, AFP, sFlt-1, PSA, hEGF, TFF2, TFF3, CA199, CA50, TK1

Regardless of the advances in the cancer therapy, delayed symptoms and lack of successful diagnosis of cancer at early stage increased the death rate. Tumor-associated antigens (TAAs) and their antibodies have been identified as potential markers in cancer diagnosis and determination. TAAs and their antibodies-based detection of cancer have the advantages such as low-cost, and simple access, which attracted much attention for early cancer detection. For several reasons, tumor marker itself is typically insufficient to analyze disease conditions. Because, maximum number of markers have been produced by both normal and cancer cells. Several cancers such as anal, breast, ovaries, testicles, colon, endometrial, peritoneal, fallopian tube, gallbladder, gastric, liver, lung, neuroendocrine, pancreatic, prostate, renal, cervix, stomach and thyroid cancer, bronchopulmonary dysplasia, hepatitis, hematological malignancies, hemochromatosis, hypercalcemia, osteoporosis, Parget’s diseases and so on have been identified using specific marker. Detecting the quantity of marker proteins from different samples may benefit from ELISA, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT.